Abeona Therapeutics Inc vs abrdn Physical Palladium Shares ETF — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while abrdn Physical Palladium Shares ETF trades at $25.4. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, abrdn Physical Palladium Shares ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | PALL | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $7.45 | $37.18 |
52-Week Low | $4.17 | $19.96 |
Enterprise Value | $276.10M | — |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.
Read more on PALL →